Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Open accessThe DOI matches its Crossref record; 159 of the 160 references it cites were found in a registry or an index.
Abstract
Some tissue types give rise to human cancers millions of times more often than other tissue types. Although this has been recognized for more than a century, it has never been explained. Here, we show that the lifetime risk of cancers of many different types is strongly correlated (0.81) with the total number of divisions of the normal self-renewing cells maintaining that tissue's homeostasis. These results suggest that only a third of the variation in cancer risk among tissues is attributable to environmental factors or inherited predispositions. The majority is due to "bad luck," that is, random mutations arising during DNA replication in normal, noncancerous stem cells. This is important not only for understanding the disease but also for designing strategies to limit the mortality it causes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cancer formation is the result of the stochastic intracellular accumulation of spontaneous mutations during DNA replication, combined with the environment exposure and lifestyle habits, both able to significantly influence cancer risk [3,4].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Self-citationOstrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Self-citationMutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Simplified calculation of body surface area
(1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171717 · Cited by 3,238
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Research works printed but not linked: 1
- Dubai PM Laryngoscope 124 1877 1881 2014 24474667
Cited by
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
“A recent study shows how knowing the number of cells in different tissues can be an important indicator in understand variation in cancer risk among tissues (Tomasetti and Vogelstein, 2015).”
BackgroundPan-cancer analysis of whole genomes
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064
“In support of this, we found an inverse correlation between previously estimated rates of stem cell division across tissues 82 and the frequency of telomere maintenance abnormalities ( P = 0.01, Poisson regression) (Extended Data Fig.”
MethodInfluentialCholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
“Small bile duct and cholangiolocarcinoma iCCA usually develop on a background of chronic liver disease (such as chronic viral hepatitis and cirrhosis) 38,46,70 , characterized by HpSC activation 71,73,74 .”
BackgroundEDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
Current and future perspectives of liquid biopsies in genomics-driven oncology
Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0071-5 · Cited by 1,557
Endogenous DNA damage as a source of genomic instability in cancer
Tubbs, A., & Nussenzweig, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.002 · Cited by 1,452
Somatic mutation in cancer and normal cells
Martincorena, I., & Campbell, P. J. (2015) · Science · doi:10.1126/science.aab4082 · Cited by 1,396
The molecular landscape of head and neck cancer
Leemans, C. R., Snijders, P. J. F., & Brakenhoff, R. H. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2018.11 · Cited by 1,395
Revisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 1,272
Clonal hematopoiesis in human aging and disease
Jaiswal, S., & Ebert, B. L. (2019) · Science · doi:10.1126/science.aan4673 · Cited by 1,156
“The error rate of eukaryotic DNA replication tends to be very low, except in the case where DNA mismatch repair function is compromised (10, 11) The number of replication cycles that a cell has undergone typically increases with age; therefore the number of polymerase errors also cumulatively increases (12).”
Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention
Tomasetti, C., Li, L., & Vogelstein, B. (2017) · Science · doi:10.1126/science.aaf9011 · Cited by 1,113
Self-citationTargeting the tumour stroma to improve cancer therapy
Valkenburg, K. C., de Groot, A. E., & Pienta, K. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0007-1 · Cited by 1,084
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
DNA methylation aging clocks: challenges and recommendations
Bell, C. G., Lowe, R., Adams, P. D., Baccarelli, A. A., Beck, S., Bell, J. T., Christensen, B. C., Gladyshev, V. N., Heijmans, B. T., Horvath, S., et al. (2019) · Genome Biology · doi:10.1186/s13059-019-1824-y · Cited by 1,025
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Marusyk, A., Janiszewska, M., & Polyak, K. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.007 · Cited by 1,009
“Whereas the sufficiency of these baseline replication error rates to account for carcinogenesis remains a subject of debate (Beckman and Loeb, 2006; Tomasetti and Vogelstein, 2015; Tomlinson et al., 1996), many tumors display increased mutation rates, due to either increased external or internal…”
BackgroundTissue-specific mutation accumulation in human adult stem cells during life
Blokzijl, F., de Ligt, J., Jager, M., Sasselli, V., Roerink, S., Sasaki, N., Huch, M., Boymans, S., Kuijk, E., Prins, P., et al. (2016) · Nature · doi:10.1038/nature19768 · Cited by 935
High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
Beyaz, S., Mana, M. D., Roper, J., Kedrin, D., Saadatpour, A., Hong, S.-J., Bauer-Rowe, K. E., Xifaras, M. E., Akkad, A., Arias, E., et al. (2016) · Nature · doi:10.1038/nature17173 · Cited by 845
Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management
Shah, S. C., & Itzkowitz, S. H. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.10.035 · Cited by 838
DNA Methylation in Cancer and Aging
Klutstein, M., Nejman, D., Greenfield, R., & Cedar, H. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3278 · Cited by 810
“Thus, in principle, there must be other factors that control this phenomenon in vivo, most of which are probably related to the specific developmental history of each primary cell type (18).”
BackgroundIntra-tumor heterogeneity from a cancer stem cell perspective
Prasetyanti, P. R., & Medema, J. P. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0600-4 · Cited by 800
“A contemporary mathematical model supports this view by demonstrating a nearly perfect correlation between cancer risk and the rate of stem cell division, suggesting highly replicative stem cells as alleged target for mutation and hence, neoplastic transformation [36].”
BackgroundThe broken cycle: E2F dysfunction in cancer
Kent, L. N., & Leone, G. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0143-7 · Cited by 800
Rising incidence of early-onset colorectal cancer — a call to action
Akimoto, N., Ugai, T., Zhong, R., Hamada, T., Fujiyoshi, K., Giannakis, M., Wu, K., Cao, Y., Ng, K., & Ogino, S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00445-1 · Cited by 728
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shalapour, S., & Karin, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80007 · Cited by 698
“Such findings and others counter the recent suggestion that cancer rates and risks are purely dictated by the number of cancer-initiating cell divisions (42).”
The mathematics of cancer: integrating quantitative models
Altrock, P. M., Liu, L. L., & Michor, F. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4029 · Cited by 685
Substantial contribution of extrinsic risk factors to cancer development
Wu, S., Powers, S., Zhu, W., & Hannun, Y. A. (2016) · Nature · doi:10.1038/nature16166 · Cited by 666
The role of the microbiome in cancer development and therapy
Bhatt, A. P., Redinbo, M. R., & Bultman, S. J. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21398 · Cited by 653
Bray, F., Ferlay, J., Laversanne, M., Brewster, D. H., Gombe Mbalawa, C., Kohler, B., Piñeros, M., Steliarova‐Foucher, E., Swaminathan, R., Antoni, S., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29670 · Cited by 643
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard, P., Shulman, S., Farhat, D., Steyaert, J.-M., Alifano, M., & Lincet, H. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.001 · Cited by 643
Principles of DNA methylation and their implications for biology and medicine
Dor, Y., & Cedar, H. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31268-6 · Cited by 640
Early‐onset colorectal cancer in young individuals
Mauri, G., Sartore‐Bianchi, A., Russo, A., Marsoni, S., Bardelli, A., & Siena, S. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12417 · Cited by 634
Is early-onset cancer an emerging global epidemic? Current evidence and future implications
Ugai, T., Sasamoto, N., Lee, H.-Y., Ando, M., Song, M., Tamimi, R. M., Kawachi, I., Campbell, P. T., Giovannucci, E. L., Weiderpass, E., et al. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00672-8 · Cited by 603
Khwaja, A., Bjorkholm, M., Gale, R. E., Levine, R. L., Jordan, C. T., Ehninger, G., Bloomfield, C. D., Estey, E., Burnett, A., Cornelissen, J. J., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.10 · Cited by 592
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
“Cancer formation is the result of the stochastic intracellular accumulation of spontaneous mutations during DNA replication, combined with the environment exposure and lifestyle habits, both able to significantly influence cancer risk [3,4].”
BackgroundA causal mechanism for childhood acute lymphoblastic leukaemia
Greaves, M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0015-6 · Cited by 558
Dow, L. E., O’Rourke, K. P., Simon, J., Tschaharganeh, D. F., van Es, J. H., Clevers, H., & Lowe, S. W. (2015) · Cell · doi:10.1016/j.cell.2015.05.033 · Cited by 552
“Alternatively, the mouse-human differences in previous models may be due to species-specific changes in stem cell behavior (Tomasetti and Vogelstein, 2015).”
Intra-tumour diversification in colorectal cancer at the single-cell level
Roerink, S. F., Sasaki, N., Lee-Six, H., Young, M. D., Alexandrov, L. B., Behjati, S., Mitchell, T. J., Grossmann, S., Lightfoot, H., Egan, D. A., et al. (2018) · Nature · doi:10.1038/s41586-018-0024-3 · Cited by 551
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Raveh, E., Matouk, I. J., Gilon, M., & Hochberg, A. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0458-2 · Cited by 525
Determinants of telomere length across human tissues
Demanelis, K., Jasmine, F., Chen, L. S., Chernoff, M., Tong, L., Delgado, D., Zhang, C., Shinkle, J., Sabarinathan, M., Lin, H., et al. (2020) · Science · doi:10.1126/science.aaz6876 · Cited by 515
“Estimates of stem cell division and proportion of stem cells were extracted from prior studies (54, 55) for corresponding GTEx tissues, and their relationship with average RTL and TERT expression was examined.”
MethodThe Telomeres Mendelian Randomization Collaboration, Haycock, P. C., Burgess, S., Nounu, A., Zheng, J., Okoli, G. N., Bowden, J., Wade, K. H., Timpson, N. J., Evans, D. M., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5945 · Cited by 513
RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues
Yizhak, K., Aguet, F., Kim, J., Hess, J. M., Kübler, K., Grimsby, J., Frazer, R., Zhang, H., Haradhvala, N. J., Rosebrock, D., et al. (2019) · Science · doi:10.1126/science.aaw0726 · Cited by 500
“All are expected to be more prominent in tissues with a higher cell proliferation rate (37, 38).”
BackgroundHybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer
Font-Burgada, J., Shalapour, S., Ramaswamy, S., Hsueh, B., Rossell, D., Umemura, A., Taniguchi, K., Nakagawa, H., Valasek, M. A., Ye, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.026 · Cited by 486
“The lifetime risk of most cancers, including HCC, was proposed to correlate with the cumulative number of cell divisions in the corresponding stem cell compartment (Tomasetti and Vogelstein, 2015).”
Abegglen, L. M., Caulin, A. F., Chan, A., Lee, K., Robinson, R., Campbell, M. S., Kiso, W. K., Schmitt, D. L., Waddell, P. J., Bhaskara, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.13134 · Cited by 485
Lamb, R., Ozsvari, B., Lisanti, C. L., Tanowitz, H. B., Howell, A., Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3174 · Cited by 478
“These observations are also consistent with the idea that cancer is essentially a disease of “stemness” gone awry [7, 8].”
BackgroundResultThe future of early cancer detection
Fitzgerald, R. C., Antoniou, A. C., Fruk, L., & Rosenfeld, N. (2022) · Nature Medicine · doi:10.1038/s41591-022-01746-x · Cited by 457
FXR Regulates Intestinal Cancer Stem Cell Proliferation
Fu, T., Coulter, S., Yoshihara, E., Oh, T. G., Fang, S., Cayabyab, F., Zhu, Q., Zhang, T., Leblanc, M., Liu, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.036 · Cited by 456
Nutrition, inflammation and cancer
Zitvogel, L., Pietrocola, F., & Kroemer, G. (2017) · Nature Immunology · doi:10.1038/ni.3754 · Cited by 446
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
Grimwade, D., Ivey, A., & Huntly, B. J. P. (2016) · Blood · doi:10.1182/blood-2015-07-604496 · Cited by 445
“Recent controversial datahave alsobeenpresented to suggest that cancer risk in agiven tissue canbe at least partially explainedby the predicted number of stem cell divisions within that tissue.(71) Examination of the hematopoietic system has provided supporting evidence for this hypothesis, where WGS sequencing has de…”
BackgroundEvaluating intrinsic and non-intrinsic cancer risk factors
Wu, S., Zhu, W., Thompson, P., & Hannun, Y. A. (2018) · Nature Communications · doi:10.1038/s41467-018-05467-z · Cited by 437
Pancreatic cancer biology and genetics from an evolutionary perspective
Makohon-Moore, A., & Iacobuzio-Donahue, C. A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.66 · Cited by 431
The distribution of cellular turnover in the human body
Sender, R., & Milo, R. (2021) · Nature Medicine · doi:10.1038/s41591-020-01182-9 · Cited by 420
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Soetaert, F., Korangath, P., Serantes, D., Fiering, S., & Ivkov, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.025 · Cited by 406
DNA methylation loss in late-replicating domains is linked to mitotic cell division
Zhou, W., Dinh, H. Q., Ramjan, Z., Weisenberger, D. J., Nicolet, C. M., Shen, H., Laird, P. W., & Berman, B. P. (2018) · Nature Genetics · doi:10.1038/s41588-018-0073-4 · Cited by 405
“Tissue types with high stem cell turnover 35 including liver, colon, skin, and pancreas displayed the strongest PMD hypomethylation.”
Evolutionary Determinants of Cancer
Greaves, M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0439 · Cited by 395
“If Tomasetti and Vogelstein were correct, this would be a lost cause for most types of cancers, which they ascribe to chance mutation alone (170).”
BackgroundFanconi anaemia and cancer: an intricate relationship
Nalepa, G., & Clapp, D. W. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.116 · Cited by 389
Batty, G. D., Russ, T. C., Stamatakis, E., & Kivimäki, M. (2017) · BMJ · doi:10.1136/bmj.j108 · Cited by 377
Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment
Aponte, P. M., & Caicedo, A. (2017) · Stem Cells International · doi:10.1155/2017/5619472 · Cited by 375
“During carcinogenesis any cell type is prone to malignant transformation depending on the degree of accumulation of nononcogenic or oncogenic mutations [21, 100].”
Clocchiatti, A., Cora, E., Zhang, Y., & Dotto, G. P. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.30 · Cited by 374
Testa, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
“In support of this hypothesis, the analysis of 31 different tissues showed the existence of a good correlation between number of stem cell divisions and the lifetime risk of developing cancer [502].”
ResultThe Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks
Aunan, J. R., Cho, W. C., & Søreide, K. (2017) · Aging and disease · doi:10.14336/ad.2017.0103 · Cited by 373
“Yet, it also represents the stochastic risk of accumulating changes that fosters uncontrolled cell division and expansion in cancer, evidenced by the higher lifetime cancer risk of tissues requiring many cell divisions for homeostasis, indicating that the number one cause of tissue cancer variation is just "bad luck"…”
BackgroundThymic involution and rising disease incidence with age
Palmer, S., Albergante, L., Blackburn, C. C., & Newman, T. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714478115 · Cited by 364
Cancer as a disease of old age: changing mutational and microenvironmental landscapes
Laconi, E., Marongiu, F., & DeGregori, J. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0721-1 · Cited by 348
Goodell, M. A., & Rando, T. A. (2015) · Science · doi:10.1126/science.aab3388 · Cited by 347
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Carbone, M., Adusumilli, P. S., Alexander, H. R., Baas, P., Bardelli, F., Bononi, A., Bueno, R., Felley‐Bosco, E., Galateau‐Salle, F., Jablons, D., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21572 · Cited by 335
When stem cells grow old: phenotypes and mechanisms of stem cell aging
Schultz, M. B., & Sinclair, D. A. (2016) · Development · doi:10.1242/dev.130633 · Cited by 331
“In fact, the lifetime risk of cancer arising in a tissue correlates with the number of divisions its stem cells have made (Tomasetti and Vogelstein, 2015).”
BackgroundCorrelation of an epigenetic mitotic clock with cancer risk
Yang, Z., Wong, A., Kuh, D., Paul, D. S., Rakyan, V. K., Leslie, R. D., Zheng, S. C., Widschwendter, M., Beck, S., & Teschendorff, A. E. (2016) · Genome Biology · doi:10.1186/s13059-016-1064-3 · Cited by 325
The mutual interplay of gut microbiota, diet and human disease
Illiano, P., Brambilla, R., & Parolini, C. (2020) · The FEBS Journal · doi:10.1111/febs.15217 · Cited by 322
Goodson, W. H., Lowe, L., Carpenter, D. O., Gilbertson, M., Manaf Ali, A., Lopez de Cerain Salsamendi, A., Lasfar, A., Carnero, A., Azqueta, A., Amedei, A., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv039 · Cited by 322
“Additionally, it is well known that some tissue types give rise to human cancers millions of times more often than other tissue types (498).”
BackgroundSquamous Cell Cancers: A Unified Perspective on Biology and Genetics
Dotto, G. P., & Rustgi, A. K. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.004 · Cited by 319
“…is that a large fraction of gene mutations found in tumors are already present in normal tissues (Martincorena et al., 2015; Tomasetti et al., 2013), so that accumulation and combination of these mutations may be more important than their individual occurrence (Tomasetti and Vogelstein, 2015).”
Sweeteners as food additives in the XXI century: A review of what is known, and what is to come
Carocho, M., Morales, P., & Ferreira, I. C. F. R. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.06.046 · Cited by 307
Accumulation of genetic and epigenetic alterations in normal cells and cancer risk
Takeshima, H., & Ushijima, T. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0079-0 · Cited by 300
Emerging concepts in liquid biopsies
Perakis, S., & Speicher, M. R. (2017) · BMC Medicine · doi:10.1186/s12916-017-0840-6 · Cited by 282
The oral microbiota and its role in carcinogenesis
Stasiewicz, M., & Karpiński, T. M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.002 · Cited by 282
Cancer stem cells: A review from origin to therapeutic implications
Atashzar, M. R., Baharlou, R., Karami, J., Abdollahi, H., Rezaei, R., Pourramezan, F., & Zoljalali Moghaddam, S. H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29044 · Cited by 281
“It has been shown that during DNA replication in the normal stem cells, randommutations occur, which can convert these normal stem cells to CSCs (Tomasetti & Vogelstein, 2015).”
BackgroundSong, M., & Giovannucci, E. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0843 · Cited by 279
“5; and (4) weekly aerobic physical activity of at least 75 vigorous-intensity or 150 moderate-intensity minutes (7.”
Mismatch Repair Pathway, Genome Stability and Cancer
Pećina-Šlaus, N., Kafka, A., Salamon, I., & Bukovac, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00122 · Cited by 278
“An ingenious paper (Tomasetti and Vogelstein, 2015) showed that the overall number of mitoses, stem cells carry out within a certain tissue, correlates positively with the lifetime risk of developing cancer.”
BackgroundDifferent mutational rates and mechanisms in human cells at pregastrulation and neurogenesis
Bae, T., Tomasini, L., Mariani, J., Zhou, B., Roychowdhury, T., Franjic, D., Pletikos, M., Pattni, R., Chen, B.-J., Venturini, E., et al. (2018) · Science · doi:10.1126/science.aan8690 · Cited by 271
Mosaicism in health and disease — clones picking up speed
Forsberg, L. A., Gisselsson, D., & Dumanski, J. P. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.145 · Cited by 263
The Origin of Ovarian Cancer Species and Precancerous Landscape
Shih, I.-M., Wang, Y., & Wang, T.-L. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.09.006 · Cited by 255
Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
Tomkovich, S., Yang, Y., Winglee, K., Gauthier, J., Mühlbauer, M., Sun, X., Mohamadzadeh, M., Liu, X., Martin, P., Wang, G. P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3472 · Cited by 252
Melanocytic nevi and melanoma: unraveling a complex relationship
Damsky, W. E., & Bosenberg, M. (2017) · Oncogene · doi:10.1038/onc.2017.189 · Cited by 248
Genetic Factors Are Not the Major Causes of Chronic Diseases
Rappaport, S. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154387 · Cited by 248
Sigal, M., Rothenberg, M. E., Logan, C. Y., Lee, J. Y., Honaker, R. W., Cooper, R. L., Passarelli, B., Camorlinga, M., Bouley, D. M., Alvarez, G., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.049 · Cited by 243
The molecular and cellular origin of human prostate cancer
Packer, J. R., & Maitland, N. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.02.016 · Cited by 241
Epigenome-wide association studies: current knowledge, strategies and recommendations
Campagna, M. P., Xavier, A., Lechner-Scott, J., Maltby, V., Scott, R. J., Butzkueven, H., Jokubaitis, V. G., & Lea, R. A. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01200-8 · Cited by 227
Dance to the Tune of Life: Biological Relativity
Noble, D. (2017) · Cited by 229
Hoang, M. L., Kinde, I., Tomasetti, C., McMahon, K. W., Rosenquist, T. A., Grollman, A. P., Kinzler, K. W., Vogelstein, B., & Papadopoulos, N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607794113 · Cited by 224
Self-citationCancers make their own luck: theories of cancer origins
Jassim, A., Rahrmann, E. P., Simons, B. D., & Gilbertson, R. J. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00602-5 · Cited by 221
Transcription-mediated replication hindrance: a major driver of genome instability
Gómez-González, B., & Aguilera, A. (2019) · Genes & Development · doi:10.1101/gad.324517.119 · Cited by 221
“These are hallmarks of tumorigenesis (Hills and Diffley 2014; Gaillard and Aguilera 2016), which gain additional relevance given that cancer risk increases with cell divisions (Tomasetti and Vogelstein 2015), highlighting the role of replication in genetic instability.”
BackgroundR-Squared (R 2 ) – How much variation is explained?
Gao, J. (2023) · Research Methods in Medicine & Health Sciences · doi:10.1177/26320843231186398 · Cited by 222
Payen, V. L., Porporato, P. E., Baselet, B., & Sonveaux, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2098-5 · Cited by 220
Viel, A., Bruselles, A., Meccia, E., Fornasarig, M., Quaia, M., Canzonieri, V., Policicchio, E., Urso, E. D., Agostini, M., Genuardi, M., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.022 · Cited by 217
Aging and the rise of somatic cancer-associated mutations in normal tissues
Risques, R. A., & Kennedy, S. R. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007108 · Cited by 216
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
Mu, X., Español-Suñer, R., Mederacke, I., Affò, S., Manco, R., Sempoux, C., Lemaigre, F. P., Adili, A., Yuan, D., Weber, A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77995 · Cited by 215
“In view of the recently suggested hypothesis that the number of stem cell doublings determines cancer risk across various organs (50), the hepatocyte should be seen as a fully differentiated cell with stem cell–like functions that is at risk for malignant transformation with increasing numbers of…”
The Role of Cancer Stem Cells in Radiation Resistance
Arnold, C. R., Mangesius, J., Skvortsova, I.-I., & Ganswindt, U. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00164 · Cited by 214
“CSC may originate from normal stem cells, where random mutations during DNA replication may lead to them becoming malignant (39).”
BackgroundTumor Microenvironment‐Enabled Nanotherapy
Wang, L., Huo, M., Chen, Y., & Shi, J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701156 · Cited by 213
An integrative view on sex differences in brain tumors
Sun, T., Plutynski, A., Ward, S., & Rubin, J. B. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1930-2 · Cited by 212
Modeling Pancreatic Cancer with Organoids
Baker, L. A., Tiriac, H., Clevers, H., & Tuveson, D. A. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.03.004 · Cited by 210
Current Perspectives in Cancer Immunotherapy
Christofi, T., Baritaki, S., Falzone, L., Libra, M., & Zaravinos, A. (2019) · Cancers · doi:10.3390/cancers11101472 · Cited by 210
Slieker, R. C., Relton, C. L., Gaunt, T. R., Slagboom, P. E., & Heijmans, B. T. (2018) · Epigenetics & Chromatin · doi:10.1186/s13072-018-0191-3 · Cited by 207
“A Number of aDMPs (y axis) in our study against the previously reported number of stem cell divisions per year (x axis) [47].”
Metadata
- Authors
- Tomasetti, C., & Vogelstein, B.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Tomasetti, Cristian
- Vogelstein, Bert
- Venue
- Science
- Published
- 2015-01-02
- Volume
- 347
- Issue
- 6217
- Pages
- 78-81
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4446723
- OpenAlex
- W2019078072
- Cited by
- 1,927
- References
- 160
- Citations by year
- 2026: 63 · 2025: 90 · 2024: 121 · 2023: 126 · 2022: 135 · 2021: 141 · 2020: 159 · 2019: 199 · 2018: 197 · 2017: 231 · 2016: 234 · 2015: 228
- FWCI
- 98.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (P30-CA006973, R37-CA43460, RO1-CA57345, P50-CA62924)
- The Virginia and D. K. Ludwig Fund for Cancer Research
- The Lustgarten Foundation for Pancreatic Cancer Research
- The Sol Goldman Center for Pancreatic Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- cancer risk, stem cell division, random mutation, DNA replication errors, bad luck hypothesis, cancer mortality, tissue homeostasis
- MeSH terms
- Cell Division, Humans, Mutation, Neoplasms, Risk, Stem Cells, Genetic Variation, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.